X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

被引:394
作者
Parolini, S
Bottino, C
Falco, M
Augugliaro, R
Giliani, S
Franceschini, R
Ochs, HD
Wolf, H
Bonnefoy, JY
Biassoni, R
Moretta, L
Notarangelo, LD
Moretta, A
机构
[1] Univ Genoa, Dipartimento Med Sperimentale, Sez Istol, I-16132 Genoa, Italy
[2] Univ Brescia, Dipartimento Sci Biomed & Biotecnol, I-25123 Brescia, Italy
[3] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[4] Univ Brescia, Pediat Clin, Ist Med Mol Angelo Nocivelli, I-25123 Brescia, Italy
[5] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[6] Univ Vienna, Dept Immunol, A-1090 Vienna, Austria
[7] Ctr Immunol Pierre Fabre, F-74164 St Julien En Genevois, France
关键词
X-linked lymphoproliferative disease; Epstein-Barr virus infection; natural killer cell; natural cytotoxicity receptor; 2B4; molecule;
D O I
10.1084/jem.192.3.337
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
2B4 is a surface molecule involved in activation of the natural killer (NK) cell-mediated cytotoxicity. It binds a protein termed Src homology 2 domain-containing protein (SH2D1A) or signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), which in rum has been proposed to function as a regulator of the 2B4-associated signal transduction pathway. In this study, we analyzed patients with X-linked lymphoproliferative disease (XLP), a severe inherited immunodeficiency characterized by critical mutations in the SH2D1A gene and by the inability to control Epstein-Barr Virus (EBV) infections. We show that, in these patients, 2B4 not only fails to transduce triggering signals, but also mediates a sharp inhibition of the NK-mediated cytolysis. Other receptors involved in NK cell triggering, including CD16, NKp46, NKp44, and NKp30, displayed a normal functional capability. However, their activating function was inhibited upon engagement of 2B4 molecules. CD48, the natural ligand of 2B4, is highly expressed on the surface of EBV+ B cell, lines. Remarkably, NK cells from XLP patients could not kill EBV+ B cell lines. This failure was found to be the consequence of inhibitory signals generated by the interaction between 2B4 and CD48, as the antibody-mediated disruption of the 2B4-CD48 interaction restored lysis of EBV+ target cells lacking human histocompatibility leukocyte antigen (HLA) class I molecules. In the case of autologous or allogeneic (HLA class I+) EBV+ lymphoblastoid cell lines, restoration of lysis was achieved only by the simultaneous disruption of 2B4-CD48 and NK receptor-HLA class I interactions. Molecular analysis revealed that 2B4 molecules isolated from either XLP or normal NK cells were identical. As expected, in XLP-NK cells, 2B4 did not associate with SH2D1A, whereas similar to 2B4 molecules isolated from normal NK cells, it did associate with Src homology 2 domain-containing phosphatase 1.
引用
收藏
页码:337 / 346
页数:10
相关论文
共 42 条
[1]   Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4 [J].
Boles, KS ;
Nakajima, H ;
Colonna, M ;
Chuang, SS ;
Stepp, SE ;
Bennett, M ;
Kumar, V ;
Mathew, PA .
TISSUE ANTIGENS, 1999, 54 (01) :27-34
[2]  
BOLHUIS RLH, 1986, J IMMUNOL, V136, P3939
[3]   The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering [J].
Bottino, C ;
Biassoni, R ;
Millo, R ;
Moretta, L ;
Moretta, A .
HUMAN IMMUNOLOGY, 2000, 61 (01) :1-6
[4]   2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090
[5]  
Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO
[6]  
2-L
[7]   NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily [J].
Cantoni, C ;
Bottino, C ;
Vitale, M ;
Pessino, A ;
Augugliaro, R ;
Malaspina, A ;
Parolini, S ;
Moretta, L ;
Moretta, A ;
Biassoni, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :787-795
[8]   SELF CLASS-I MOLECULES PROTECT NORMAL-CELLS FROM LYSIS MEDIATED BY AUTOLOGOUS NATURAL-KILLER-CELLS [J].
CICCONE, E ;
PENDE, D ;
VITALE, M ;
NANNI, L ;
DIDONATO, C ;
BOTTINO, C ;
MORELLI, L ;
VIALE, O ;
AMOROSO, A ;
MORETTA, A ;
MORETTA, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) :1003-1006
[9]   A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION [J].
COCKS, BG ;
CHANG, CCJ ;
CARBALLIDO, JM ;
YSSEL, H ;
DEVRIES, JE ;
AVERSA, G .
NATURE, 1995, 376 (6537) :260-263
[10]   Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].
Coffey, AJ ;
Brooksbank, RA ;
Brandau, O ;
Oohashi, T ;
Howell, GR ;
Bye, JM ;
Cahn, AP ;
Durham, J ;
Heath, P ;
Wray, P ;
Pavitt, R ;
Wilkinson, J ;
Leversha, M ;
Huckle, E ;
Shaw-Smith, CJ ;
Dunham, A ;
Rhodes, S ;
Schuster, V ;
Porta, G ;
Yin, L ;
Serafini, P ;
Sylla, B ;
Zollo, M ;
Franco, B ;
Bolino, A ;
Seri, M ;
Lanyi, A ;
Davis, JR ;
Webster, D ;
Harris, A ;
Lenoir, G ;
St Basile, GD ;
Jones, A ;
Behloradsky, BH ;
Achatz, H ;
Murken, J ;
Fassler, R ;
Sumegi, J ;
Romeo, G ;
Vaudin, M ;
Ross, MT ;
Meindl, A ;
Bentley, DR .
NATURE GENETICS, 1998, 20 (02) :129-135